AB SCIEX MDQ PLus

The Centers for Disease Control and Prevention (CDC) within the Department of Health and Human Services is seeking a sole source firm fixed price equipment maintenance contract for preventative and remedial maintenance, as well as software upgrades, for AB Sciex PACE MDQ Plus Capillary Systems operated by the Biotechnology Core Facility Branch (BCFB). This procurement is being pursued under the authority of FAR 13.106-1(b) (Simplified Acquisition Procedures) and 10 U.S.C. 2304(c)(1), which permits sole source procurement in specific circumstances. The primary objective is to ensure compliance with the Quality Management System (QMS) requirements through continuous equipment maintenance and support. While this is not a competitive solicitation, interested vendors are permitted to submit expressions of interest and capability statements demonstrating their qualifications to respond to the requirement. All quotations and responses must be submitted via email to the Contracting Officer at uex0@cdc.gov by 5:00 PM Eastern Time on December 31, 2025, and the government retains sole discretion in determining whether to proceed with competitive procurement based on responses received.

This procurement carries no set-aside designations and identifies AB Sciex LLC as the intended sole source contractor. The contract is structured with a firm fixed price arrangement and includes an initial period of performance from January 17, 2026, through January 16, 2027, with four optional one-year renewal periods available, potentially extending the contract through January 2031. The notice does not specify an explicit contract value or budget range, though the equipment maintenance classification under NAICS 811210 and PSC J066 suggests routine technical support services. The 15-day response window from the posting date of December 16, 2025, to the submission deadline of December 31, 2025, provides potential competitors a limited timeframe to prepare and submit their responses for the government's consideration.